The abstract is read at the publisher; the summary is JClub's.
Liver X receptor (LXR) signaling is linked to cholesterol efflux and tumor growth in hepatocellular carcinoma, with disrupted LXR activity associated with impaired cholesterol export.
- Why it matters: Metabolic dysfunction-associated steatotic liver disease often progresses to MASH and then HCC, and current therapeutic approaches face the challenge of LXRs’ paradoxical metabolic effects.
- What they did: This review synthesizes evidence on LXRs as transcriptional regulators of fatty acid synthesis and cholesterol balance, emphasizing how activation versus inhibition can shift lipid handling and inflammation.
- The result: Stage- and cell type-specific LXR-targeting strategies are implied to be necessary to avoid worsening liver injury while addressing MASH and hepatocarcinogenesis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.